Absence of kelch13 artemisinin resistance markers but strong selection for lumefantrine-tolerance molecular markers following 18 years of artemisinin-based combination therapy use in Mpumalanga Province, South Africa (2001-2018). [electronic resource]
Producer: 20191126Description: 280 p. digitalISSN:- 1475-2875
- Antimalarials -- pharmacology
- Artemisinins -- pharmacology
- Diagnostic Tests, Routine
- Drug Combinations
- Drug Resistance -- genetics
- Drug Therapy, Combination
- Genetic Markers
- Lumefantrine -- pharmacology
- Plasmodium falciparum -- drug effects
- Protozoan Proteins -- genetics
- Pyrimethamine -- pharmacology
- Selection, Genetic
- South Africa
- Sulfadoxine -- pharmacology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.